# POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test

> **NCT04981769** · — · UNKNOWN · sponsor: **Anavasi Diagnostics** · enrollment: 1000 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Covid-19 test

## Key facts

- **NCT ID:** NCT04981769
- **Lead sponsor:** Anavasi Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-02
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2021-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04981769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04981769, "POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04981769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*